• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Real Estate·600162.SS
Share

Shenzhen HeungKong Holding Co.,Ltd Stocks

CN¥ 3.09Last Updated 05.11.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.48B

CN¥ 3.09
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shenzhen HeungKong Holding Co.,Ltd, established in 1994 and headquartered in Guangzhou, China, primarily functions as a real estate development firm operating across China. However, its business interests are highly diversified. The company also manages land, oversees property, and executes construction and decoration projects. Its wider services encompass corporate image planning, hotel management, educational and economic consulting, domestic trade, retail space rental, and various management functions including supply chain, investment, and marketing. Furthermore, HeungKong Holding has a significant presence in the healthcare and wellness sector, managing physical examination centers, offering nutrition and health consulting, administering hospitals, operating nursing homes and elderly care facilities, and providing specialized logistics for medical institutions. This extensive portfolio also includes warehousing services and the technical research and development of both medical devices and health products.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA, overvalued on

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

05.11.2026 20:20

The Nasdaq 100 Index Plunged 4% as Investors Dump AI Stocks After the Election: Online

05.11.2026 20:08

Pharmaceutical giant Sanofi sent the stock of small biotech company Nurix plummeting. What will happen to the stock next?

05.11.2026 19:39

"A rotation is underway": Chipmakers' stocks plummeted as the Dow Jones rose

05.11.2026 18:58

Apple shares have hit a record high—they're considered a safe bet. Is there still room for growth?

05.11.2026 18:21

Airlines in Europe have faced a second wave of bomb threats

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026